ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,567.19
      1.06%
      US Tech 100
      19,832.40
      0.97%
      Dow Jones
      39,375.87
      0.17%
      Brent Oil
      86.535
      -0.91%
      Bitcoin
      56,406.14
      -1.01%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE
      6. Hikma Pharmaceuticals Plc (HIK)

      7. Hikma Pharmaceuticals Plc (HIK) News

      HIK

      Hikma Pharmaceuticals (HIK)

      Hikma Pharmaceuticals Plc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:LSE:HIK
      DateTimeSourceHeadlineSymbolCompany
      11/04/20213:00AMUK RegulatoryHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
      11/01/202110:06AMUK RegulatoryHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
      10/22/20218:00AMPR Newswire (US)Hikma donates 50,000 doses of injectable naloxone to help expand non-profit access to lifesaving treatment for reversing opioid overdosesLSE:HIKHikma Pharmaceuticals Plc
      10/04/20214:55AMUK RegulatoryHikma Pharmaceuticals Plc Block listing Interim ReviewLSE:HIKHikma Pharmaceuticals Plc
      09/27/20213:16AMAlliance NewsAlliance NewsTOP NEWS: Hikma buys US injectables firm Custopharm for USD375 millionLSE:HIKHikma Pharmaceuticals Plc
      09/27/20213:16AMAlliance NewsAlliance NewsTOP NEWS: Hikma buys US injectables firm Custopharm for USD375 millionLSE:HIKHikma Pharmaceuticals Plc
      09/27/20212:00AMUK RegulatoryHikma Pharmaceuticals Plc Hikma acquires CustopharmLSE:HIKHikma Pharmaceuticals Plc
      09/27/20212:00AMPR Newswire (US)Hikma strengthens US Injectables business through acquisition of CustopharmLSE:HIKHikma Pharmaceuticals Plc
      09/23/20212:29AMUK RegulatoryHikma Pharmaceuticals Plc Additional ListingLSE:HIKHikma Pharmaceuticals Plc
      09/20/20211:30PMPR Newswire (US)Hikma and FAES Farma enter into exclusive licensing agreement for the commercialisation of Bilastine tablets in the USLSE:HIKHikma Pharmaceuticals Plc
      09/06/20215:42AMUK RegulatoryHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
      08/27/20218:27AMAlliance NewsAlliance NewsHikma Pharmaceuticals inks deal to commercialise Bio-Thera antibodyLSE:HIKHikma Pharmaceuticals Plc
      08/27/20218:27AMAlliance NewsAlliance NewsHikma Pharmaceuticals inks deal to commercialise Bio-Thera antibodyLSE:HIKHikma Pharmaceuticals Plc
      08/27/20218:26AMAlliance NewsAlliance NewsHikma Pharmaceuticals inks deal to commercialise Bio-Thera antibodyLSE:HIKHikma Pharmaceuticals Plc
      08/27/20218:26AMAlliance NewsAlliance NewsHikma Pharmaceuticals inks deal to commercialise Bio-Thera antibodyLSE:HIKHikma Pharmaceuticals Plc
      08/27/20217:15AMRNS Non-RegulatoryHikma Pharmaceuticals Plc Bio-Thera and Hikma announce exclusive agreementLSE:HIKHikma Pharmaceuticals Plc
      08/06/20213:40AMAlliance NewsAlliance NewsTOP NEWS: Hikma hikes Generics guidance as interim profit swellsLSE:HIKHikma Pharmaceuticals Plc
      08/06/20213:40AMAlliance NewsAlliance NewsTOP NEWS: Hikma hikes Generics guidance as interim profit swellsLSE:HIKHikma Pharmaceuticals Plc
      08/06/20212:00AMUK RegulatoryHikma Pharmaceuticals Plc Half-year ReportLSE:HIKHikma Pharmaceuticals Plc
      08/04/20218:00AMPR Newswire (US)Hikma announces US launch of KLOXXADO™ (naloxone HCl) nasal spray 8mgLSE:HIKHikma Pharmaceuticals Plc
      08/02/20219:48AMUK RegulatoryHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
      07/19/20214:27AMUK RegulatoryHikma Pharmaceuticals Plc Notice of ResultsLSE:HIKHikma Pharmaceuticals Plc
      07/05/202110:43AMUK RegulatoryHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
      06/09/20218:00AMPR Newswire (US)Hikma appoints Patrick Genestin to lead Generics Business DevelopmentLSE:HIKHikma Pharmaceuticals Plc
      06/02/20218:14AMUK RegulatoryHikma Pharmaceuticals Plc Total Voting RightsLSE:HIKHikma Pharmaceuticals Plc
      05/17/202111:00AMUK RegulatoryHikma Pharmaceuticals Plc Director/PDMR ShareholdingLSE:HIKHikma Pharmaceuticals Plc
      04/30/20213:58AMAlliance NewsAlliance NewsTOP NEWS: Hikma Pharma confident after promising start to yearLSE:HIKHikma Pharmaceuticals Plc
      04/30/20213:58AMAlliance NewsAlliance NewsTOP NEWS: Hikma Pharma confident after promising start to yearLSE:HIKHikma Pharmaceuticals Plc
      04/30/20212:00AMUK RegulatoryHikma Pharmaceuticals Plc Trading StatementLSE:HIKHikma Pharmaceuticals Plc
      04/30/20212:00AMPR Newswire (US)Hikma announces US FDA approval of KLOXXADOTM (naloxone hydrochloride) nasal spray 8mgLSE:HIKHikma Pharmaceuticals Plc
       Showing the most relevant articles for your search:LSE:HIK